Browsing Tag
VOCERYQ
1 post
Inovio Pharmaceuticals (INO) surges 240% after FDA approval, but can its first DNA medicine deliver commercial success?
Inovio Pharmaceuticals has secured accelerated US approval for VOCERYQ, its first commercial product and the country's first approved plasmid DNA-based immunotherapy. Shares surged in extended trading, but the company faces a demanding transition from drug development to commercial operations, with limited cash runway and a confirmatory clinical trial still required.